Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

Prabhakara V Choudary, M. Molnar, S. J. Evans, H. Tomita, J. Z. Li, M. P. Vawter, R. M. Myers, W. E. Bunney, H. Akil, S. J. Watson, E. G. Jones

Research output: Contribution to journalArticle

423 Citations (Scopus)

Abstract

Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLCIA2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABAA receptor subunits, of which GABAAα1 and GABAAβ3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.

Original languageEnglish (US)
Pages (from-to)15653-15658
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number43
DOIs
StatePublished - Oct 25 2005

Fingerprint

Neuroglia
Glutamic Acid
Depression
Glutamate-Ammonia Ligase
Neutral Amino Acid Transport Systems
Amino Acid Transport System X-AG
Major Depressive Disorder
Glutamate Receptors
GABA-A Receptors
Microarray Analysis
Glutamine
Cerebral Cortex
gamma-Aminobutyric Acid
Suicide
Up-Regulation
Down-Regulation
Biomarkers
Pharmacology
Enzymes
Proteins

Keywords

  • Bipolar disorder
  • GABA receptors
  • Glutamate transporters
  • Major depression
  • Suicide

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. / Choudary, Prabhakara V; Molnar, M.; Evans, S. J.; Tomita, H.; Li, J. Z.; Vawter, M. P.; Myers, R. M.; Bunney, W. E.; Akil, H.; Watson, S. J.; Jones, E. G.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 43, 25.10.2005, p. 15653-15658.

Research output: Contribution to journalArticle

Choudary, PV, Molnar, M, Evans, SJ, Tomita, H, Li, JZ, Vawter, MP, Myers, RM, Bunney, WE, Akil, H, Watson, SJ & Jones, EG 2005, 'Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression', Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15653-15658. https://doi.org/10.1073/pnas.0507901102
Choudary, Prabhakara V ; Molnar, M. ; Evans, S. J. ; Tomita, H. ; Li, J. Z. ; Vawter, M. P. ; Myers, R. M. ; Bunney, W. E. ; Akil, H. ; Watson, S. J. ; Jones, E. G. / Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 43. pp. 15653-15658.
@article{55764790f5d94ba1866499834b9da0dd,
title = "Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression",
abstract = "Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLCIA2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABAA receptor subunits, of which GABAAα1 and GABAAβ3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.",
keywords = "Bipolar disorder, GABA receptors, Glutamate transporters, Major depression, Suicide",
author = "Choudary, {Prabhakara V} and M. Molnar and Evans, {S. J.} and H. Tomita and Li, {J. Z.} and Vawter, {M. P.} and Myers, {R. M.} and Bunney, {W. E.} and H. Akil and Watson, {S. J.} and Jones, {E. G.}",
year = "2005",
month = "10",
day = "25",
doi = "10.1073/pnas.0507901102",
language = "English (US)",
volume = "102",
pages = "15653--15658",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "43",

}

TY - JOUR

T1 - Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

AU - Choudary, Prabhakara V

AU - Molnar, M.

AU - Evans, S. J.

AU - Tomita, H.

AU - Li, J. Z.

AU - Vawter, M. P.

AU - Myers, R. M.

AU - Bunney, W. E.

AU - Akil, H.

AU - Watson, S. J.

AU - Jones, E. G.

PY - 2005/10/25

Y1 - 2005/10/25

N2 - Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLCIA2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABAA receptor subunits, of which GABAAα1 and GABAAβ3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.

AB - Abnormalities in L-glutamic acid (glutamate) and GABA signal transmission have been postulated to play a role in depression, but little is known about the underlying molecular determinants and neural mechanisms. Microarray analysis of specific areas of cerebral cortex from individuals who had suffered from major depressive disorder demonstrated significant down-regulation of SLCIA2 and SLC1A3, two key members of the glutamate/neutral amino acid transporter protein family, SLC1. Similarly, expression of L-glutamate-ammonia ligase, the enzyme that converts glutamate to nontoxic glutamine was significantly decreased. Together, these changes could elevate levels of extracellular glutamate considerably, which is potentially neurotoxic and can affect the efficiency of glutamate signaling. The astroglial distribution of the two glutamate transporters and L-glutamate-ammonia ligase strongly links glia to the pathophysiology of depression and challenges the conventional notion that depression is solely a neuronal disorder. The same cortical areas displayed concomitant up-regulation of several glutamate and GABAA receptor subunits, of which GABAAα1 and GABAAβ3 showed selectivity for individuals who had died by suicide, indicating their potential utility as biomarkers of suicidality. These findings point to previously undiscovered molecular underpinnings of the pathophysiology of major depression and offer potentially new pharmacological targets for treating depression.

KW - Bipolar disorder

KW - GABA receptors

KW - Glutamate transporters

KW - Major depression

KW - Suicide

UR - http://www.scopus.com/inward/record.url?scp=27344456829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27344456829&partnerID=8YFLogxK

U2 - 10.1073/pnas.0507901102

DO - 10.1073/pnas.0507901102

M3 - Article

C2 - 16230605

AN - SCOPUS:27344456829

VL - 102

SP - 15653

EP - 15658

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 43

ER -